We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
+5.71%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$752M
AUM Growth
+$110M
(+17%)
Cap. Flow
+$81.1M
Cap. Flow
% of AUM
10.79%
Top 10 Holdings %
Top 10 Hldgs %
40.28%
Holding
184
New
49
Increased
34
Reduced
33
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$17.2M |
| 2 |
Oracle
ORCL
|
+$13.2M |
| 3 |
Zimmer Biomet
ZBH
|
+$12.5M |
| 4 |
NGD
New Gold Inc
NGD
|
+$10.2M |
| 5 |
Incyte
INCY
|
+$9.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$17.2M |
| 2 |
SSNI
Silver Spring Networks, Inc.
SSNI
|
+$12.8M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$8.48M |
| 4 |
BRG
Bluerock Residential Growth REIT, Inc.
BRG
|
+$8.05M |
| 5 |
MarketAxess Holdings
MKTX
|
+$7.04M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.31% |
| 2 | Technology | 13.37% |
| 3 | Materials | 7.6% |
| 4 | Utilities | 6.6% |
| 5 | Industrials | 5.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Golar LNG
GLNG
$4.82B
| $9.5M | 1.26% |
420,000
-52,500
| -11% | -$1.15M |
|
|
NSM
27
CALL
DELISTED
Nationstar Mortgage Holdings
NSM
| $9.29M | 1.23% |
500,000
| – | – |
|
|
CLVS
28
DELISTED
Clovis Oncology, Inc.
CLVS
| $9.27M | 1.23% |
+112,500
| New | +$8.92M |
|
29
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$300M
| $9.11M | 1.21% |
256,000
+250,000
| +4,167% | +$8.82M |
|
|
30
Incyte
INCY
$25.4B
| $9.05M | 1.2% |
77,500
+75,000
| +3,000% | +$9.49M |
|
31
CALL
FedEx
FDX
$73B
| $9.05M | 1.2% |
+40,100
| New | +$8.54M |
|
|
PEGI
32
DELISTED
Pattern Energy Group Inc. Class A
PEGI
| $8.72M | 1.16% |
362,000
-255,500
| -41% | -$6.35M |
|
33
ServiceNow
NOW
$120B
| $8.7M | 1.16% |
370,000
-30,000
| -8% | -$667K |
|
|
34
FedEx
FDX
$73B
| $8.47M | 1.13% |
+37,550
| New | +$7.99M |
|
35
American Superconductor
AMSC
$1.29B
| $8.33M | 1.11% |
1,835,000
+445,000
| +32% | +$1.73M |
|
36
Alibaba
BABA
$276B
| $8.12M | 1.08% |
47,000
-8,000
| -15% | -$1.3M |
|
37
Lumentum
LITE
$46.9B
| $7.75M | 1.03% |
142,500
+5,500
| +4% | +$320K |
|
|
CTLP
38
DELISTED
Cantaloupe
CTLP
| $7.47M | 0.99% |
1,195,000
+795,000
| +199% | +$4.28M |
|
39
Adobe
ADBE
$105B
| $7.46M | 0.99% |
50,000
-40,000
| -44% | -$5.97M |
|
|
SHLM
40
DELISTED
Schulman (A.) Inc
SHLM
| $6.83M | 0.91% |
+200,000
| New | +$5.96M |
|
41
GoDaddy
GDDY
$13.9B
| $6.74M | 0.9% |
155,000
+35,000
| +29% | +$1.51M |
|
42
Expedia Group
EXPE
$36.5B
| $6.69M | 0.89% |
46,500
+41,500
| +830% | +$6.15M |
|
|
HCR
43
DELISTED
Hi-Crush Inc. Common Stock
HCR
| $6.03M | 0.8% |
635,000
+75,000
| +13% | +$659K |
|
|
44
CALL
Golar LNG
GLNG
$4.82B
| $5.99M | 0.8% |
265,000
+225,000
| +563% | +$4.94M |
|
45
Neurocrine Biosciences
NBIX
$18.2B
| $5.97M | 0.79% |
97,500
+92,500
| +1,850% | +$4.88M |
|
46
Element Solutions
ESI
$8.48B
| $5.52M | 0.73% |
495,000
-5,000
| -1% | -$61.9K |
|
|
FOLD
47
DELISTED
Amicus Therapeutics
FOLD
| $5.5M | 0.73% |
+365,000
| New | +$4.83M |
|
|
CARB
48
DELISTED
Carbonite Inc
CARB
| $5.39M | 0.72% |
245,000
+95,000
| +63% | +$2.01M |
|
49
Canadian Solar
CSIQ
$932M
| $5.06M | 0.67% |
300,500
-267,500
| -47% | -$4.38M |
|
|
FNSR
50
DELISTED
Finisar Corp
FNSR
| $4.82M | 0.64% |
+217,500
| New | +$5.33M |
|
Similar funds
NA
MK
QIM
JVBC
TFP
UWPG
LOAMU
PHS
Ardsley Advisory Partners's Q3 2017 Portfolio in Review
As of Q3 2017, Ardsley Advisory Partners held 184 positions worth $752M, up 17% from $642M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Ardsley Advisory Partners deployed $81.1M of net new capital in Q3 2017, opening 49 new positions and adding to 34 existing holdings. Its largest new stake was Centene: 400,000 shares worth $19.4M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 12% a quarter earlier, followed by Technology and Materials.
On the sell side, the largest reduction was Celgene Corp, an estimated $17.2M trimmed.
- Ardsley Advisory Partners's largest Q3 2017 buy was Centene: 400,000 shares worth $19.4M.
- Ardsley Advisory Partners added most to Zimmer Biomet in Q3 2017, an estimated $12.5M increase.
- Ardsley Advisory Partners's biggest Q3 2017 reduction was Celgene Corp, cutting an estimated $17.2M.
- Ardsley Advisory Partners fully exited Bluerock Residential Growth REIT, Inc. in Q3 2017, selling an estimated $8.05M.
- Ardsley Advisory Partners's ten largest holdings make up 40% of its $752M portfolio in Q3 2017.
- Ardsley Advisory Partners opened 49 new positions and closed 54 in Q3 2017.
- Ardsley Advisory Partners's portfolio value rose 17% quarter-over-quarter to $752M.
Based on Ardsley Advisory Partners's 13F filing for Q3 2017, filed 14 Nov 2017.